Abstract
ObjectivesTo evaluate the long-term efficacy and safety of canakinumab to treat patients with colchicine-resistant familial Mediterranean fever (crFMF) during Epoch 4 (weeks 41 to 113) of the CLUSTER study.MethodsPatients received...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have